Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW – Get Free Report) shares were up 20% during mid-day trading on Thursday . The stock traded as high as $0.12 and last traded at $0.12. Approximately 1,041 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 20,179 shares. The stock had previously closed at $0.10.
Rocket Pharmaceuticals Trading Down 8.3 %
The firm has a 50-day moving average price of $0.07 and a two-hundred day moving average price of $0.12.
Rocket Pharmaceuticals Company Profile
Rocket Pharmaceuticals, Inc, together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.
Further Reading
- Five stocks we like better than Rocket Pharmaceuticals
- Transportation Stocks Investing
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Most Volatile Stocks, What Investors Need to Know
- MarketBeat Week in Review – 9/16 – 9/20
- Upcoming IPO Stock Lockup Period, Explained
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Rocket Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
